{"id":"W2287692022","doi":"10.1200/jco.2007.25.18_suppl.lba7514","title":"Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"ca_institutions":"Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gemcitabine; Carboplatin; Bevacizumab; Clinical endpoint; Placebo; Oncology; Cisplatin; Chemotherapy; Lung cancer; Progression-free survival; Neutropenia; Surgery; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001132798,0.0002078344,0.001399698,0.0002853929,0.00003268644,0.000006488763,0.00008343526,0.0001659572,0.0000313281],"category_scores_gemma":[0.0001367321,0.0001227137,0.00008182452,0.0003261234,0.00008175019,0.0001369627,0.00001905601,0.0005627473,2.268047e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004205073,"about_ca_system_score_gemma":0.001242368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002193136,"about_ca_topic_score_gemma":0.004674742,"domain_scores_codex":[0.996971,0.0001106007,0.002038619,0.0002630008,0.0003577498,0.0002590496],"domain_scores_gemma":[0.9963198,0.0009718197,0.001768671,0.0001429264,0.0005668871,0.0002298658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5068745,0.0256417,0.3734148,0.00007803748,0.0002794692,0.0002485109,0.003225622,0.0001489734,0.00002494374,6.928568e-7,0.0000181057,0.09004462],"study_design_scores_gemma":[0.6400554,0.0360572,0.321095,0.0003513751,0.0006345056,0.000009338645,0.001259781,0.0002958951,0.00008003884,0.000001472622,0.00006343899,0.00009656604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995102,0.0002965372,0.0002010992,0.0003106874,0.0002673432,0.003491644,0.000005000896,0.000003293907,0.0003223927],"genre_scores_gemma":[0.99795,0.0002905584,0.001378179,0.0001442295,0.00008274861,0.0000547036,0.00001109875,0.00002366725,0.00006481787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1331809,"threshold_uncertainty_score":0.5004119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03669029450550364,"score_gpt":0.4493433680146531,"score_spread":0.4126530735091495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}